Related Experiment Video

Updated: Jun 19, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

Evidence- and Consensus-based European Guideline for Immunosuppressive Therapy After Pediatric Kidney Transplantation

Anna Grünewald1, Thurid Ahlenstiel-Grunow1, Zainab Arslan2

  • 1Department of Pediatrics II, University Hospital of Essen, Essen, Germany.

Transplantation
|June 17, 2026
PubMed

Insights

This guideline offers updated recommendations for immunosuppressive therapy in pediatric kidney transplant recipients. It addresses variable international practices and aims to improve patient and graft survival through evidence-based strategies.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Medicine
  • Immunosuppression Therapy

Background:

  • Limited evidence exists for immunosuppressive therapy in pediatric kidney transplant recipients, leading to variable international practices.
  • Current clinical practice recommendations for individualized immunosuppression are often not implemented, potentially impacting patient and graft survival.
  • Lack of standardized protocols necessitates updated guidelines for optimal post-transplant care in children.

Purpose of the Study:

  • To provide evidence- and consensus-based recommendations for immunosuppressive therapy in pediatric kidney transplant recipients.
  • To standardize and improve the implementation of immunosuppressive strategies in pediatric kidney transplantation.
  • To enhance patient and renal allograft survival through optimized immunosuppression protocols.

Main Methods:

  • Development of a guideline between January 2024 and December 2025.
  • Adherence to the Guidance Manual of the German Association of Scientific Medical Societies.
  • Collaboration between multiple German and international pediatric nephrology, nephrology, transplantation, and pediatrics societies.

Main Results:

  • The guideline presents up-to-date, state-of-the-art recommendations for immunosuppressive therapy post-kidney transplantation in pediatric patients.
  • It is founded on the best available evidence and expert consensus from relevant medical societies.
  • Provides a framework for individualized immunosuppressive strategies tailored to pediatric kidney transplant recipients.

Conclusions:

  • Formal consensus was achieved, particularly crucial for areas with weak or inconclusive evidence.
  • The guideline emphasizes expert opinion where evidence is limited, ensuring comprehensive recommendations.
  • Aims to guide clinical practice towards improved outcomes in pediatric kidney transplantation.
Abstract

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...